Question explored with the scientific record
What is the best alternative therapy for squamous cell carcinoma
The retrieved evidence does not test a single alternative therapy for squamous cell carcinoma; the question cannot be answered from these records.
None of the 28 studies examine a non-standard treatment for this cancer. The closest subjects are HPV-related cervical, oropharynx, and nail-unit lesions [1, 3, 4, 5], and those are descriptive or risk-factor studies, not therapy trials. One study describes an in-vitro screening method for drugs targeting HPV E6 protein binding [2], which is a lab tool, not a therapy. There is no data here on diet, herbs, supplements, photodynamic therapy, topical agents, or any other alternative approach for squamous cell carcinoma.
The retrieval simply missed the entire literature on this topic. A meaningful answer would require studies that directly compare a specific alternative therapy—such as topical 5-fluorouracil, imiquimod, photodynamic therapy, or dietary interventions—against standard care or watchful waiting, with hard outcomes like recurrence, progression, or mortality. Those were not captured.
My call: no evidence was retrieved. Confidence: not clear
Sources used 5
-
p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers
This study investigates the association between the p53 codon 72 polymorphism and the risk of human papillomavirus (HPV)-associated squamous cell carcinoma of the oropharynx (SCCOP) in never-smokers, finding that variant genotypes significantly increase the risk, particularly in…
DOI: 10.1093/carcin/bgn039 -
Development of screening systems for drugs against human papillomavirus-associated cervical cancer: based on E6-E6AP binding
This study develops an in vitro screening system for potential drugs against human papillomavirus (HPV)-associated cervical cancer by investigating the binding interaction between the HPV E6 protein and the E6-associated protein (E6AP).
DOI: 10.1016/s0166-3542(00)00109-1 -
Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix
This study investigates the relationship between the codon 72 polymorphism of the p53 gene and the risk of developing human papillomavirus (HPV)-associated squamous intraepithelial lesions (SIL) and invasive cervical cancer in Japanese patients, finding no significant associatio…
DOI: 10.1093/carcin/20.9.1733 -
The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma
This study analyzes the demographic distribution of human papillomavirus (HPV)-associated oropharynx squamous cell carcinoma (OPC) in the United States using data from the National Cancer Data Base, revealing significant variations in HPV prevalence across different socioeconomi…
DOI: 10.1002/ijc.30442 -
Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas
This study investigates the molecular etiology of second primary tumors (SPTs) in contralateral tonsils of patients with human papillomavirus (HPV)-associated tonsillar carcinomas, finding that the same HPV-16 variant is present in both the index and SPTs, suggesting a common vi…
DOI: 10.1016/j.oraloncology.2012.09.009